Lansing Street Advisors’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.82M Sell
495,422
-58,241
-11% -$252K 0.6% 34
2026
Q1
$2.14M Buy
553,663
+6,625
+1% +$27.2K 0.54% 37
2025
Q4
$2.29M Hold
547,038
0.58% 29
2025
Q3
$1.8M Buy
+547,038
New +$1.54M 0.48% 36

Other funds holding PGEN

Lansing Street Advisors's PGEN Position: Q2 2026 in Review

Lansing Street Advisors reduced its Precigen (PGEN) stake by 11% in Q2 2026, selling an estimated $252K and leaving 495,422 shares worth $2.82M. The position accounts for 0.6% of the portfolio, ranked #34.

Lansing Street Advisors first reported a position in PGEN in Q3 2025 and has held it in 4 quarters since. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Lansing Street Advisors held 495,422 shares of Precigen worth $2.82M as of Q2 2026.
  • Lansing Street Advisors sold 58,241 Precigen shares in Q2 2026, an estimated $252K.
  • Precigen made up 0.6% of Lansing Street Advisors's portfolio in Q2 2026, its #34 holding.
  • Lansing Street Advisors first reported a position in Precigen in Q3 2025 and has held it in 4 quarters since.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Lansing Street Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.